Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | STAT3 | P40763 | 17/20 | 0.81 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Loganic Acid SCHEMBL29426077 | 1.00 | MAPT (1.00) | MAPTSTAT3MEN1KMT2A | |
| Loganic Acid SCHEMBL31179995 | 1.00 | MAPT (1.00) | MAPTSTAT3MEN1KMT2A | |
| SCHEMBL29426057 | 0.90 | STAT3 (0.85) | MAPTSTAT3MEN1KMT2A | |
| Loganin SCHEMBL21114425 | 0.90 | STAT3 (1.00) | MAPTSTAT3MEN1KMT2A | |
| Loganin SCHEMBL29425815 | 0.90 | STAT3 (1.00) | MAPTSTAT3MEN1KMT2A | |
| Loganin SCHEMBL23805433 | 0.90 | STAT3 (1.00) | MAPTSTAT3MEN1KMT2A | |
| Loganin SCHEMBL307017 | 0.90 | STAT3 (1.00) | MAPTSTAT3MEN1KMT2A | |
| Loganin SCHEMBL23805434 | 0.90 | STAT3 (1.00) | MAPTSTAT3MEN1KMT2A | |
| Loganin SCHEMBL29402517 | 0.90 | STAT3 (1.00) | MAPTSTAT3MEN1KMT2A | |
| SCHEMBL29426175 | 0.88 | MAPT (0.79) | MAPTSTAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250354108-A1 | METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS | UNIV DANMARKS TEKNISKE (DK) | 2025-11-20 | — | — | US | claimed |
| EP-4379068-B1 | IRIDOID OR SECO-IRIDOID DERIVATIVES AND THEIR USE IN A TANNING PROCESS | INSTITUT NAT DES SCIENCES APPLIQUEES DE ROUEN (FR) | 2025-06-04 | — | — | EP | claimed |
| EP-4526426-A2 | METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS | Danmarks Tekniske Universitet (DK) | 2025-03-26 | — | — | EP | claimed |
| WO-2024168348-A1 | PRODUCTION OF MONOTERPENE INDOLE ALKALOID COMPOUNDS IN A HETEROLOGOUS HOST | TRYPTAGENIX, INC. (US) | 2024-08-15 | — | — | WO | claimed |
| EP-4379068-A1 | IRIDOID OR SECO-IRIDOID DERIVATIVES AND THEIR USE IN A TANNING PROCESS | Institut National Des Sciences Appliquées De Rouen (FR) | 2024-06-05 | — | — | EP | claimed |
| WO-2024023440-A1 | NOVEL COSMETIC OR DERMATOLOGICAL USE OF A GENTIANA CRASSICAULIS EXTRACT | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2024-02-01 | — | — | WO | claimed |
| WO-2023222879-A2 | METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS | DANMARKS TEKNISKE UNIVERSITET (DK) | 2023-11-23 | — | — | WO | claimed |
| US-20230172945-A1 | APPLICATION OF COMPOUNDS IN CONTROLLING OR KILLING MITES | Guangzhou Medical University Property Operation Limited Corporation (CN) | 2023-06-08 | — | — | US | claimed |
| US-20230165922-A1 | APPLICATION OF RADIX GENTIANAE MACROPHYLLAE AND MONOMER COMPOUND THEREOF IN KILLING MITES | Guangzhou Medical University Property Operation Limited Corporation (CN) | 2023-06-01 | — | — | US | claimed |
| EP-4129316-A1 | APPLICATION OF RADIX GENTIANAE MACROPHYLLAE AND MONOMER COMPOUND THEREOF IN KILLING MITES | Smilebiotek Zhuhai Limited (CN) | 2023-02-08 | — | — | EP | claimed |
| CN-105572261-A | Method for building fingerprint spectrum of Xianlinggubao capsules and quality detection method of Xianlinggubao capsules | GUOYAOJITUAN TONGJITANG (GUIZHOU) PHARMACEUTICAL CO LTD | 2016-05-11 | — | — | CN | claimed |
| WO-2015198346-A1 | A COMPOSITION COMPRISING EXTRACT OF ALANGIUM SALVIFOLIUM HAVING ANTI-ADIPOGENIC OR ANTI-OBESIC ACTIVITY | LAILA NUTRACEUTICALS (IN) | 2015-12-30 | — | — | WO | claimed |
| CN-105129950-A | Processing agent removing erythromycin, roxithromycin and azithromycin in pharmaceutical factory waste water | HANGZHOU QICHENG TECHNOLOGY CO LTD | 2015-12-09 | — | — | CN | claimed |
| CN-105084487-A | Method for removing erythromycin, roxithromycin and azithromycin in wastewater of pharmaceutical factory | HANGZHOU QICHENG TECHNOLOGY CO LTD | 2015-11-25 | — | — | CN | claimed |
| CN-104391072-A | Quality control method of traditional Chinese medicine compound preparation for treating osteoporosis | GUANGZHOU BAIYUNSHAN JINGXIUTANG PHARMACEUTICAL COMPANY LTD | 2015-03-04 | — | — | CN | claimed |
| CN-102188476-B | Composition of effective Chinese medicine components for treating hepatic fibrosis | SHI JIN | 2013-03-06 | — | — | CN | claimed |
| US-20100227827-A1 | METHOD OF INCREASING TRYPTOPHAN AND NICOTINAMIDE LEVELS IN VIVO | GENETIC HEALTH ENTERPRISES (PTY) LTD. (ZA) | 2010-09-09 | — | — | US | claimed |
| US-20090123581-A1 | COLLAGEN CROSS-LINKING AGENTS ON DENTAL RESTORATIVE TREATMENT AND PREVENTIVE DENTISTRY | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2009-05-14 | — | — | US | claimed |
| WO-2008008837-A2 | A METHOD OF INCREASING TRYPTOPHAN AND NICOTINAMIDE LEVELS IN VIVO | LYNPETE TRADING 6 (PTY) LTD. TRADING AS GENETIC HEALTH ENTERPRISES (ZA) | 2008-01-17 | — | — | WO | claimed |
| WO-2007146841-A2 | COLLAGEN CROSS-LINKING AGENTS ON DENTAL RESTORATIVE TREATMENT AND PREVENTIVE DENTISTRY | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2007-12-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100227827-A1 | METHOD OF INCREASING TRYPTOPHAN AND NICOTINAMIDE LEVELS IN VIVO | NNMT, AADAT, AANAT | MAPT 1466/4885STAT3 2119/4885MEN1 4449/4885 |
| US-20230172945-A1 | APPLICATION OF COMPOUNDS IN CONTROLLING OR KILLING MITES | DSTN, DDT, TYR | MAPT 2729/4885STAT3 3951/4885MEN1 806/4885 |
| US-20250354108-A1 | METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS | INMT, KARS1, MIA3 | MAPT 3008/4885STAT3 1898/4885MEN1 423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.